Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Chief Accounting Officer | October 04, 2016 | October 06, 2016 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | SVP, Finance and CAO | August 06, 2026 | August 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date October 04, 2016 · Filed October 06, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,839 |
Reported balance
After 2016-10-04 transaction · row 1
1 source rowRow 1 · 2016-10-04 · Grant · Acquired 1,839 · Balance 1,839 F1: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.19 · Expires 2026-10-04 | Direct | 5,856 |
Reported balance
After 2016-10-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-04 · Grant · Acquired 5,856 · Balance 5,856 F2: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017.
F2: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date August 06, 2026 · Filed August 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,852 |
Ending reported balance
After 2026-08-06 transaction · row 12
12 source rows · reconciled sequenceRow 1 · 2026-08-06 · Sale · Disposed 1,274 · Balance 14,878 F1: This transaction was executed in multiple trades at prices ranging from $258.77 to $259.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 2 · 2026-08-06 · Sale · Disposed 901 · Balance 13,977 F2: This transaction was executed in multiple trades at prices ranging from $259.97 to $260.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2026-08-06 · Sale · Disposed 810 · Balance 13,167 F3: This transaction was executed in multiple trades at prices ranging from $261.00 to $261.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2026-08-06 · Sale · Disposed 213 · Balance 12,954 F4: This transaction was executed in multiple trades at prices ranging from $262.26 to $262.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2026-08-06 · Sale · Disposed 620 · Balance 12,334 F5: This transaction was executed in multiple trades at prices ranging from $263.39 to $264.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 6 · 2026-08-06 · Sale · Disposed 482 · Balance 11,852 F6: This transaction was executed in multiple trades at prices ranging from $264.91 to $265.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 7 · 2026-08-06 · Exercise / conversion · Acquired 404 · Balance 12,256 Row 8 · 2026-08-06 · Exercise / conversion · Acquired 1,205 · Balance 13,461 Row 9 · 2026-08-06 · Exercise / conversion · Acquired 736 · Balance 14,197 Row 10 · 2026-08-06 · Sale · Disposed 404 · Balance 13,793 Row 11 · 2026-08-06 · Sale · Disposed 1,205 · Balance 12,588 Row 12 · 2026-08-06 · Sale · Disposed 736 · Balance 11,852 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.66 · Expires 2030-05-29 | Direct | 0 |
Reported balance
After 2026-08-06 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-08-06 · Exercise / conversion · Disposed 404 · Balance 0 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $194.12 · Expires 2033-05-26 | Direct | 402 |
Reported balance
After 2026-08-06 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-08-06 · Exercise / conversion · Disposed 1,205 · Balance 402 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.44 · Expires 2034-05-31 | Direct | 736 |
Reported balance
After 2026-08-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-08-06 · Exercise / conversion · Disposed 736 · Balance 736 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $258.77 to $259.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $259.97 to $260.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $261.00 to $261.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $262.26 to $262.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $263.39 to $264.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $264.91 to $265.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2023 Filed Jun 2, 2023 19:31 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017494 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,940 F1 · shares: The Restricted Stock Units vest as follows: 764 on June 1, 2025 and 764 on June 1, 2027. Read SEC document |
| May 29, 2023 Filed May 31, 2023 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 36 | $194.12 | $6,988.32 |
DisclosureSEC source: 0001127602-23-017225 · form4.xml · nonDerivative · entry 4 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,412 Read SEC document |
| May 28, 2023 Filed May 31, 2023 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 24 | $194.12 | $4,658.88 |
DisclosureSEC source: 0001127602-23-017225 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,448 Read SEC document |
| May 27, 2023 Filed May 31, 2023 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 36 | $194.12 | $6,988.32 |
DisclosureSEC source: 0001127602-23-017225 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,472 Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,607 | $194.12 Strike: $194.12 | $311,950.84 |
DisclosureSEC source: 0001127602-23-017225 · form4.xml · derivative · entry 5 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607 Underlying: Common Stock · 1,607 shares Expires 2033-05-26 F2 · shares: Stock Options vest as follows: 401 on May 26, 2024, 402 on May 26, 2025, 402 on May 26, 2026 and 402 on May 26, 2027. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017225 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,508 F1 · shares: Restricted Stock Units vest as follows: 167 on May 26, 2024, 167 on May 26, 2025, 168 on May 26, 2026 and 168 on May 26, 2027. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 21:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 51 | $243.60 | $12,423.60 |
DisclosureSEC source: 0001127602-23-006485 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,838 Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 645 | $244.29 | $157,567.05 |
DisclosureSEC source: 0001127602-23-002663 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,889 Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002663 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,534 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 22:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 855 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-22-025979 · form4.xml · derivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 855 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 22:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 855 | $248.59 | $212,544.45 |
DisclosureSEC source: 0001127602-22-025979 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,438 Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 22:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 855 | $109.34 | $93,485.70 |
DisclosureSEC source: 0001127602-22-025979 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2022 Filed May 31, 2022 22:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 54 | $244.41 | $13,198.14 |
DisclosureSEC source: 0001127602-22-016062 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,438 Read SEC document |
| May 28, 2022 Filed May 31, 2022 22:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 37 | $244.41 | $9,043.17 |
DisclosureSEC source: 0001127602-22-016062 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,492 Read SEC document |
| May 27, 2022 Filed May 31, 2022 22:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,327 | $244.41 Strike: $244.41 | $324,332.07 |
DisclosureSEC source: 0001127602-22-016062 · form4.xml · derivative · entry 4 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,327 Underlying: Common Stock · 1,327 shares Expires 2032-05-27 F2 · shares: Stock Options vest as follows: 331 on May 27, 2023, 332 on May 27, 2024, 332 on May 27, 2025 and 332 on May 27, 2026. Read SEC document |
| May 27, 2022 Filed May 31, 2022 22:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016062 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,529 F1 · shares: Unvested restricted stock units vest as follows: 122 on May 27, 2023, 123 on May 27, 2024, 123 on May 27, 2025 and 123 on May 27, 2026. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 21:31 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 56 | $289.58 | $16,216.48 |
DisclosureSEC source: 0001127602-22-006304 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,038 Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:31 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 51 | $293.61 | $14,974.11 |
DisclosureSEC source: 0001127602-22-006304 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,094 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 826 | $312.24 | $257,910.24 |
DisclosureSEC source: 0001127602-22-002795 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002795 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,971 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 404 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · derivative · entry 7 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 404 shares Expires 2030-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 735 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · derivative · entry 6 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471 Underlying: Common Stock · 735 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 388 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · derivative · entry 5 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 Underlying: Common Stock · 388 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,527 | $335.24 | $511,905.98 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · nonDerivative · entry 4 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,230 F1 · price: This transaction was executed in multiple trades at prices ranging from $335.17 to $335.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 404 | $179.66 | $72,582.64 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 735 | $144.67 | $106,332.45 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 388 | $109.34 | $42,423.92 |
DisclosureSEC source: 0001127602-21-019395 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 13:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 467 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-21-019153 · form4.xml · derivative · entry 5 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 467 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 13:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 333 | $0.00 Strike: $90.43 | $0.00 |
DisclosureSEC source: 0001127602-21-019153 · form4.xml · derivative · entry 4 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 333 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 13:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $329.76 | $263,808.88 |
DisclosureSEC source: 0001127602-21-019153 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,230 F1 · price: This transaction was executed in multiple trades at prices ranging from $329.7552 to $329.8020. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 13:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 467 | $109.34 | $51,061.78 |
DisclosureSEC source: 0001127602-21-019153 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 13:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 333 | $90.43 | $30,113.19 |
DisclosureSEC source: 0001127602-21-019153 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2021 Filed Jun 1, 2021 22:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 54 | $337.99 | $18,251.46 |
DisclosureSEC source: 0001127602-21-018565 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,230 Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,006 | $337.99 Strike: $337.99 | $340,017.94 |
DisclosureSEC source: 0001127602-21-018565 · form4.xml · derivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006 Underlying: Common Stock · 1,006 shares Expires 2031-05-28 F2 · shares: Stock Options vest as follows: 251 on May 28, 2022, 252 on May 28, 2023, 251 on May 28, 2024 and 252 on May 28, 2025. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018565 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,284 F1 · shares: Unvested restricted stock units vest as follows: 81 on May 28, 2022, 81 on May 28, 2023, 81 on May 28, 2024 and 82 on May 28, 2025. Read SEC document |
| May 01, 2021 Filed May 4, 2021 19:59 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 93 | $332.45 | $30,917.85 |
DisclosureSEC source: 0001127602-21-015162 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,959 Read SEC document |
| February 23, 2021 Filed Feb 23, 2021 16:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 84 | $283.59 | $23,821.56 |
DisclosureSEC source: 0001127602-21-007207 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,052 Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 16:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 62 | $289.55 | $17,952.10 |
DisclosureSEC source: 0001127602-21-007207 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,136 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 16:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 410 | $290.99 | $119,304.51 |
DisclosureSEC source: 0001127602-21-007207 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,198 Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 16:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 953 | $260.88 | $248,618.64 |
DisclosureSEC source: 0001127602-21-003430 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,608 Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 16:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 3,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003430 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,561 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 23, 2018. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 735 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · derivative · entry 8 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,206 Underlying: Common Stock · 735 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,709 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · derivative · entry 7 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,710 Underlying: Common Stock · 1,709 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 997 | $0.00 Strike: $90.43 | $0.00 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · derivative · entry 6 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333 Underlying: Common Stock · 997 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 663 | $216.93 | $143,823.79 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · nonDerivative · entry 5 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,399 F2 · price: This transaction was executed in multiple trades at prices ranging from $216.88 to $217.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,793 | $216.52 | $604,731.70 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · nonDerivative · entry 4 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,062 F1 · price: This transaction was executed in multiple trades at prices ranging from $215.87 to $216.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 735 | $144.67 | $106,332.45 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · nonDerivative · entry 3 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 1,709 | $109.34 | $186,862.06 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · nonDerivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 19:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 997 | $90.43 | $90,158.71 |
DisclosureSEC source: 0001127602-20-023220 · form4.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 18:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,616 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001127602-20-018388 · form4.xml · derivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · CSVP&Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,616 Underlying: Common Stock · 1,616 shares Expires 2030-05-29 F2 · shares: Stock Options vest in one-fourth increments on May 29, 2021, 2022, 2023 and 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.